Nanox (NASDAQ: NNOX) announced a distribution agreement with Costa Rica-based medical equipment distributor SOLME RC, S.A. to market and support the Nanox.ARC, a multi-source digital tomosynthesis system designed to expand access to 3D medical imaging. Under the agreement, SOLME will oversee marketing, distribution, installation, training and ongoing technical support in Costa Rica, where it is a registered supplier to the Caja Costarricense de Seguro Social (CCSS), the country's principal purchaser and provider of hospital services. The deal marks Nanox's third Latin American market this year, following Argentina and Peru, signaling the company's accelerating push into underserved regions.
The importance of this announcement lies in its potential to broaden access to advanced medical imaging in a market where such technology is often limited. The Nanox.ARC is a cost-effective, 3D multi-source digital tomosynthesis imaging system designed for ease of use and scalability. By partnering with SOLME, which has established ties to the CCSS, Nanox aims to integrate its system into Costa Rica's public healthcare infrastructure. Commercialization will follow applicable regulatory registration, including an initial six-month proof-of-concept device registration period before full registration. This phased approach allows for clinical validation and local adaptation, which could serve as a blueprint for other markets.
For Nanox, the agreement advances its vision of driving the world's transition to preventive health care by delivering an integrated, end-to-end medical imaging and healthcare services platform. The company combines affordable imaging hardware, advanced AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to care. The Nanox ecosystem includes Nanox.ARC; Nanox.AI, a suite of AI-based algorithms that augment the interpretation of routine CT imaging to identify early signs often associated with chronic disease; Nanox.CLOUD, a cloud-based platform for secure data management, storage, and advanced imaging analytics; Nanox.MARKETPLACE and USARAD Holdings, which provide access to remote radiology and cardiology experts and comprehensive teleradiology services; and Nanox Health IT, which combines deep healthcare IT expertise with leading technology partners to deliver RIS, PACS, AI, dictation, and secure infrastructure solutions that streamline workflows and support safer, more efficient care delivery.
By integrating imaging technology, AI, cloud infrastructure, clinical expertise, a marketplace, and health information technology, Nanox seeks to lower barriers to adoption, improve utilization, and advance preventive care worldwide. The Costa Rica agreement is a concrete step toward that goal, particularly in a region where access to advanced imaging can be constrained. For SOLME, the partnership adds a differentiated imaging solution to its portfolio and strengthens its position as a supplier to the CCSS. For patients in Costa Rica, the arrival of the Nanox.ARC could mean earlier detection of disease and more efficient workflows, aligning with global efforts to shift from reactive to preventive care.
The full press release is available at https://ibn.fm/C77lJ. The latest news and updates relating to NNOX are available in the company's newsroom at https://ibn.fm/NNOX. Forward-looking statements involve risks and uncertainties, and undue reliance should not be placed on them.
